Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Heads Up! A Novel Provocative Maneuver To Guide Acute Ischemic Stroke Management
Cerebrovascular Disease and Interventional Neurology
(-)
107
Authors/Disclosures
Latisha Sharma, MD (UCLA Comprehensive Stroke Center) Dr. Sharma has nothing to disclose.
Francesca Cicchetti No disclosure on file
Jeffrey L. Saver, MD, FÂé¶¹´«Ã½Ó³»­ (UCLA Health) Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovus. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim (prevention only). Dr. Saver has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Medical Association. Dr. Saver has received stock or an ownership interest from Rapid Medical.
Doojin Kim, MD (UCLA) No disclosure on file
Indranil Sen-Gupta, MD Dr. Sen-Gupta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global Advisors.
Sidney Starkman, MD, FÂé¶¹´«Ã½Ó³»­ (UCLA Emergency Medicine Center) No disclosure on file
Bruce I. Ovbiagele, MD, MSc, FÂé¶¹´«Ã½Ó³»­ (San Francisco VA) Dr. Ovbiagele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Stroke Association. Dr. Ovbiagele has received research support from National Institutes of Health. Dr. Ovbiagele has a non-compensated relationship as a President with Society for Equity Neuroscience that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities. Dr. Ovbiagele has a non-compensated relationship as a Board Member with World Stroke Organization that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities.
Brian H. Buck, MD No disclosure on file
Nerses Sanossian, MD, FÂé¶¹´«Ã½Ó³»­ (Department of Neurology, USC) Dr. Sanossian has received personal compensation for serving as an employee of Univeristy of Southern California. Dr. Sanossian has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Sanossian has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Sanossian has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Portola. The institution of Dr. Sanossian has received research support from Diffusion Pharma.
Paul M. Vespa, MD, FÂé¶¹´«Ã½Ó³»­ (UCLA) Dr. Vespa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ceribell. Dr. Vespa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ceribell. Dr. Vespa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ceribell. Dr. Vespa has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for multiple. The institution of Dr. Vespa has received research support from NIH. Dr. Vespa has received intellectual property interests from a discovery or technology relating to health care.
No disclosure on file
No disclosure on file
Fernando Vinuela (UCLA Medical Ctr) No disclosure on file
David S. Liebeskind, MD, FÂé¶¹´«Ã½Ó³»­ (Neurovascular Imaging Research Core at UCLA) Dr. Liebeskind has received research support from Cerenovus. Dr. Liebeskind has received research support from Genentech . Dr. Liebeskind has received research support from Medtronic. Dr. Liebeskind has received research support from Stryker.